[New - In The Fed’s Inflation Fight, Biotech May Be The First Casualty](https://wbbsec.com/opinions-and-features/)
[New - In The Fed’s Inflation Fight, Biotech May Be The First Casualty](https://wbbsec.com/opinions-and-features/)
powered by bulletin
In: Opinions & Features

10.10.19 | Forbes

By Steve Brozak

Having just reviewed the latest UK No-Deal readiness report, it reads like a manual of administrative committee sophism. It includes specific details on the marking requirements for “Exporters of eating eggs,” but then becomes imprecise for “Suppliers of all medicines and medical products” saying they:  “should ensure they are ready to comply with the new customs and border processes required to import and export goods between the UK and the EU.” So, what will this mean to patients in need of drugs that have been tracked in short supply?

And what does this portend as October 31st approaches and voices advocating for a No-Deal Brexit suggest that a Hard Brexit is a workable option. You need only look at all of the UK travelers stranded by the Thomas Cooke travel agency bankruptcy and think will people seeking healthcare in the UK will be stranded in an eerily similar way, but with no “Rescue flights” to solve their problems.

To read the entire article on Forbes, please click here.